Obesity Clinical Trial
Official title:
The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids
The aim of this study is primarily to investigate the ability of antioxidants found in orange juice (OJ) to increase the body's sensitivity to the hormone insulin. Overweight or mildly obese women, who are otherwise healthy, will be recruited. The time commitment for subjects is ~14wks. Subjects will attend the laboratory on 5 occasions after fasting from midnight. The 1st is a medical screening. Laboratory visits 2 & 5 will take ~5hrs and will be separated by 3 months, during which time subjects will consume 250ml of an orange drink (either OJ or an orange flavoured control drink) once a day. During visits 2 & 5, subjects will have a scan to assess their %body fat using a low-dose x-ray machine, and have their insulin sensitivity measured using a technique called a 'Glucose Clamp'. During the 3hr glucose clamp, subjects receive an infusion of the hormone insulin and a glucose solution directly into their blood stream, with insulin sensitivity determined from the amount of glucose required to maintain blood glucose at normal levels. In addition, a small sample of fat tissue (about the size of a haricot bean) will be taken from underneath the skin of the belly. Subjects will record their food intake for 3-days in weeks 3, 7 and 11 of consuming the drink, and come to the lab for visits 3&4 during weeks 4&8. Laboratory visits 3&4 repeat measurements taken in the 1st (screening) visit.
Background:
Overweight and mild obesity are associated with insulin resistance and mild elevations in
lipid risk factors which are not usually sufficiently abnormal to merit treatment. Such
people are encouraged to lose weight to reduce their risk of progressing to type 2 diabetes
and coronary heart disease, but there is clearly a potential role for dietary modifications
to maximize any potential benefit of this weight loss. Flavonoids are known to have vascular
effects which might enhance substrate delivery to metabolically active tissues, and thus
improve insulin sensitivity. There are many different dietary sources of flavonoids, with
fruits such as apples, berries and citrus being rich sources. However, some researchers have
expressed concern that a high dietary intake of 100% juice may contribute to the development
of insulin resistance, obesity and the Metabolic Syndrome (Bazzano, Li et al. 2008), although
this is not universally accepted (Fujioka, Greenway et al. 2006; O'Neil and Nicklas 2008). To
date, there have been no studies investigating the effects of citrus fruits on indices of
cardio-metabolic health in people who are presently healthy but are at risk of developing
some features of the Metabolic Syndrome.
Aims:
To investigate the effects of orange juice (OJ) intake on insulin sensitivity, appetite
hormones, blood pressure and plasma lipids. In addition we aim to investigate any gene
expression changes associated with OJ consumption, in particular in adipose tissue.
Experimental protocol and methods:
Overweight or obese women (BMI 27-35), who are otherwise healthy, will be recruited onto the
study. They will attend the 'David Greenfield Human Physiology' laboratories on 5 convenient
mornings, following an overnight fast. The 1st visit is a medical screening and will involve
signing a consent form, completing medical screening, food frequency and activity
questionnaires, having height, weight, and hip/waist circumference measurements taken and a
sample of blood taken for CBC, urea, electrolytes, LFT, TFT, glucose and insulin analysis.
Subjects will then be asked to complete a 3-day diet diary for macronutrient assessment and
to consume a diet providing 50% of energy as carbohydrate for 3 days prior to the 2nd
laboratory visit. This 2nd visit will involve having a DEXA body composition scan, an adipose
tissue biopsy and a 3-hr hyperinsulinemic, euglycemic glucose clamp. Starting on the
following morning, subjects will then consume an orange drink (either OJ or a carbohydrate
matched orange flavoured drink) once a day for 12 wks. A 3-day diet diary for macronutrient
assessment will be recorded during wks 3,7and 11 of taking the drink, and measurements made
at screening will be repeated on visits 3 and 4 which will take place in weeks 4 and 8. A
standardized diet will be consumed for 3 days prior to the final laboratory visit, as before.
This 5th visit will be identical to visit 2.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |